The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons
Open accessAbstract
Summary The basis for selective death of specific neuronal populations in neurodegenerative diseases remains unclear. Parkinson's disease (PD) is a synucleinopathy characterized by a preferential loss of dopaminergic neurons in the substantia nigra (SN), whereas neurons of the ventral tegmental area (VTA) are spared. Using intracellular patch electrochemistry to directly measure cytosolic dopamine (DAcyt) in cultured midbrain neurons, we confirm that elevated DAcyt and its metabolites are neurotoxic and that genetic and pharmacological interventions that decrease DAcyt provide neuroprotection. L-DOPA increased DAcyt in SN neurons to levels 2-3-fold higher than in VTA neurons, a response dependent on dihydropyridine-sensitive Ca2+ channels, resulting in greater susceptibility of SN neurons to L-DOPA-induced neurotoxicity. DAcyt was not altered by α-synuclein deletion, although dopaminergic neurons lacking α-synuclein were resistant to L-DOPA-induced cell death. Thus, an interaction between Ca2+, DAcyt and α-synuclein may underlie the susceptibility of SN neurons in PD, suggesting multiple therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Self-citationMelanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301 · cited 1×
“Conversely, dopaminergic neurons in the VTA, which are spared in PD, produce minimal neuromelanin over a lifetime (Hirsch et al., 1988; Liang et al., 2004; Zecca et al., 2001).”
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,209
Self-citationKinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
Eisenhofer, G., Kopin, I. J., & Goldstein, D. S. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.1 · Cited by 1,072
‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C., Tkatch, T., Meredith, G. E., & Surmeier, D. J. (2007) · Nature · doi:10.1038/nature05865 · Cited by 904
Wightman, R. M., Jankowski, J. A., Kennedy, R. T., Kawagoe, K. T., Schroeder, T. J., Leszczyszyn, D. J., Near, J. A., Diliberto, E. J., & Viveros, O. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10754 · Cited by 893
Expanding insights of mitochondrial dysfunction in Parkinson's disease
Abou-Sleiman, P. M., Muqit, M. M. K., & Wood, N. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1868 · Cited by 869
Clayton, D. F., & George, J. M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01213-7 · Cited by 779
Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745 · cited 2×
“, 2008), and a likely protective action of L-DOPA therapy on the striatopallidal pathway (Day et al., 2006).”
Dopamine covalently modifies and functionally inactivates parkin
LaVoie, M. J., Ostaszewski, B. L., Weihofen, A., Schlossmacher, M. G., & Selkoe, D. J. (2005) · Nature Medicine · doi:10.1038/nm1314 · Cited by 722
Gerfen, C. R., Baimbridge, K. G., & Miller, J. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8780 · Cited by 635
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
Sulzer, D. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.009 · Cited by 587
Self-citationResistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
Dauer, W., Kholodilov, N., Vila, M., Trillat, A.-C., Goodchild, R., Larsen, K. E., Staal, R., Tieu, K., Schmitz, Y., Yuan, C. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172514599 · Cited by 581
Self-citationDopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
Ricaurte, G. A., Guillery, R. W., Seiden, L. S., Schuster, C. R., & Moore, R. Y. (1982) · Brain Research · doi:10.1016/0006-8993(82)90198-6 · Cited by 479
Tyrosine hydroxylase phosphorylation: Regulation and consequences
Dunkley, P. R., Bobrovskaya, L., Graham, M. E., Von Nagy‐Felsobuki, E. I., & Dickson, P. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02797.x · Cited by 455 · cited 2×
“It should also be noted that Ca 2+ dependent phosphorylation of TH (Dunkley et al., 2004) is likely to play a role in the absence of exogenously added L-DOPA.”
Cubells, J., Rayport, S., Rajendran, G., & Sulzer, D. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-04-02260.1994 · Cited by 448
Self-citationNeuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration
Gao, H.-M., Kotzbauer, P. T., Uryu, K., Leight, S., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0143-07.2008 · Cited by 436
Structural and metabolic brain changes in the striatum associated with methamphetamine abuse
Chang, L., Alicata, D., Ernst, T., & Volkow, N. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01782.x · Cited by 430
Sulzer, D., Bogulavsky, J., Larsen, K. E., Behr, G., Karatekin, E., Kleinman, M. H., Turro, N., Krantz, D., Edwards, R. H., Greene, L. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.11869 · Cited by 407
Self-citationLevodopa in the treatment of Parkinson's disease: Current controversies
Olanow, C. W., Agid, Y., Mizuno, Y., Albanese, A., Bonucelli, U., Damier, P., De Yebenes, J., Gershanik, O., Guttman, M., Grandas, F., et al. (2004) · Movement Disorders · doi:10.1002/mds.20243 · Cited by 370
Effect of Mutant α-Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line
Lotharius, J., Barg, S., Wiekop, P., Lundberg, C., Raymon, H. K., & Brundin, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205518200 · Cited by 352
Does levodopa slow or hasten the rate of progression of Parkinson’s disease?
Fahn, S., & and the Parkinson Study Group (2005) · Journal of Neurology · doi:10.1007/s00415-005-4008-5 · Cited by 347
Membrane properties of rat locus coeruleus neurones
Williams, J. T., North, R. A., Shefner, S. A., Nishi, S., & Egan, T. M. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90265-3 · Cited by 341
Larsen, K. E., Fon, E. A., Hastings, T. G., Edwards, R. H., & Sulzer, D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08951.2002 · Cited by 335
Self-citationPresynaptic Recording of Quanta from Midbrain Dopamine Neurons and Modulation of the Quantal Size
Pothos, E. N., Davila, V., & Sulzer, D. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-11-04106.1998 · Cited by 320
Self-citationCalcium, ageing, and neuronal vulnerability in Parkinson's disease
Surmeier, D. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70246-6 · Cited by 297
Intraneuronal dopamine-quinone synthesis: a review
Sulzer, D., & Zecca, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033289 · Cited by 284
Self-citationVed, R., Saha, S., Westlund, B., Perier, C., Burnam, L., Sluder, A., Hoener, M., Rodrigues, C. M. P., Alfonso, A., Steer, C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505910200 · Cited by 255
Thompson, L., Barraud, P., Andersson, E., Kirik, D., & Björklund, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1676-05.2005 · Cited by 248
Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
Burke, W. J., Kumar, V. B., Pandey, N., Panneton, W. M., Gan, Q., Franko, M. W., O’Dell, M., Li, S. W., Pan, Y., Chung, H. D., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0303-9 · Cited by 243
Unregulated Cytosolic Dopamine Causes Neurodegeneration Associated with Oxidative Stress in Mice
Chen, L., Ding, Y., Cagniard, B., Van Laar, A. D., Mortimer, A., Chi, W., Hastings, T. G., Kang, U. J., & Zhuang, X. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3602-07.2008 · Cited by 239
Amphetamine induces dopamine efflux through a dopamine transporter channel
Kahlig, K. M., Binda, F., Khoshbouei, H., Blakely, R. D., McMahon, D. G., Javitch, J. A., & Galli, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407737102 · Cited by 239
Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons
Sawamoto, K., Nakao, N., Kobayashi, K., Matsushita, N., Takahashi, H., Kakishita, K., Yamamoto, A., Yoshizaki, T., Terashima, T., Murakami, F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111152398 · Cited by 230
Self-citationNedergaard, S., Flatman, J. A., & Engberg, I. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019742 · Cited by 211
Synaptic Vesicle Transporter Expression Regulates Vesicle Phenotype and Quantal Size
Pothos, E. N., Larsen, K. E., Krantz, D. E., Liu, Y.-J., Haycock, J. W., Setlik, W., Gershon, M. D., Edwards, R. H., & Sulzer, D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-19-07297.2000 · Cited by 211
Self-citationBurke, W. (2004) · NeuroToxicology · doi:10.1016/s0161-813x(03)00090-1 · Cited by 211
CHEN, J., SWOPE, D., & DASHTIPOUR, K. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.021 · Cited by 206
Jaffe, E. H., Marty, A., Schulte, A., & Chow, R. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03548.1998 · Cited by 199
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.
Zecca, L., Tampellini, D., Gerlach, M., Riederer, P. F., Fariello, R. G., & Sulzer, D. L. (2001) · PubMed · doi:10.1136/mp.54.6.414 · Cited by 199
Self-citationNeuronal vulnerability in Parkinson’s disease
Hirsch, E. C., Faucheux, B., Damier, P., Mouatt-Prigent, A., & Agid, Y. (1997) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6842-4_9 · Cited by 192
Sulzer, D., Mosharov, E., Talloczy, Z., Zucca, F. A., Simon, J. D., & Zecca, L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05385.x · Cited by 191
Self-citationl‐DOPA Up‐Regulates Glutathione and Protects Mesencephalic Cultures Against Oxidative Stress
Han, S., Mytilineou, C., & Cohen, G. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020501.x · Cited by 188
Role of voltage-gated L-type Ca2+ channel isoforms for brain function
Striessnig, J., Koschak, A., Sinnegger-Brauns, M. J., Hetzenauer, A., Nguyen, N. K., Busquet, P., Pelster, G., & Singewald, N. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340903 · Cited by 185
Regulation of Quantal Size by Presynaptic Mechanisms
Sulzer, D., & Pothos, E. N. (2000) · Reviews in the Neurosciences · doi:10.1515/revneuro.2000.11.2-3.159 · Cited by 184
Self-citationMetabolic correlates of levodopa response in Parkinson’s disease
Feigin, A., Fukuda, M., Dhawan, V., Przedborski, S., Jackson–Lewis, V., Mentis, M. J., Moeller, J. R., & Eidelberg, D. (2001) · Neurology · doi:10.1212/wnl.57.11.2083 · Cited by 174
Rice, M. E., Cragg, S. J., & Greenfield, S. A. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.2.853 · Cited by 173
α-Synuclein Overexpression Increases Cytosolic Catecholamine Concentration
Mosharov, E. V., Staal, R. G. W., Bové, J., Prou, D., Hananiya, A., Markov, D., Poulsen, N., Larsen, K. E., Moore, C. M. H., Troyer, M. D., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0519-06.2006 · Cited by 165
Alvarez-Fischer, D., Henze, C., Strenzke, C., Westrich, J., Ferger, B., Höglinger, G. U., Oertel, W. H., & Hartmann, A. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.012 · Cited by 159
Burke, R. E., Antonelli, M., & Sulzer, D. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020517.x · Cited by 155
Self-citationWhy is parkinsonism not a feature of human methamphetamine users?
Moszczyńska, A., Fitzmaurice, P. S., Ang, L. C., Kalasinsky, K. S., Schmunk, G. A., Peretti, F. J., Aiken, S. S., Wickham, D. J., & Kish, S. J. (2004) · Brain · doi:10.1093/brain/awh046 · Cited by 152
Sang, T., Chang, H.-Y., Lawless, G. M., Ratnaparkhi, A., Mee, L., Ackerson, L. C., Maidment, N. T., Krantz, D. E., & Jackson, G. R. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4810-06.2007 · Cited by 151
Self-citationDopamine-modified α-synuclein blocks chaperone-mediated autophagy
Martinez-Vicente, M., Talloczy, Z., Kaushik, S., Massey, A. C., Mazzulli, J., Mosharov, E. V., Hodara, R., Fredenburg, R., Wu, D.-C., Follenzi, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32806 · Cited by 144
Self-citationIntracellular Patch Electrochemistry: Regulation of Cytosolic Catecholamines in Chromaffin Cells
Mosharov, E. V., Gong, L., Khanna, B., Sulzer, D., & Lindau, M. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05835.2003 · Cited by 143
Self-citationChien, J. B., Wallingford, R. A., & Ewing, A. G. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01918.x · Cited by 137
Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants
Pardo, B., Mena, M. A., Casarejos, M. J., Paı́no, C. L., & de Yébenes, J. G. (1995) · Brain Research · doi:10.1016/0006-8993(95)00341-m · Cited by 134
Long‐term outcome of early versus delayed rasagiline treatment in early Parkinson's disease
Hauser, R. A., Lew, M., Hurtig, H. I., Ondo, W. G., Wojcieszek, J., Fitzer‐Attas, C. J., & on behalf of the TEMPO Open‐label Study Group (2008) · Movement Disorders · doi:10.1002/mds.22402 · Cited by 129
Neurotrophic Effects of l ‐DOPA in Postnatal Midbrain Dopamine Neuron/Cortical Astrocyte Cocultures
Mena, M. A., Davila, V., & Sulzer, D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041398.x · Cited by 124
Self-citationAltered vesicular dopamine storage in Parkinson's disease: a premature demise
Caudle, W. M., Colebrooke, R. E., Emson, P. C., & Miller, G. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.010 · Cited by 122
Liang, C., Nelson, O. L., Yazdani, U., Pasbakhsh, P., & German, D. C. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20098 · Cited by 117
Identified postnatal mesolimbic dopamine neurons in culture: morphology and electrophysiology
Rayport, S., Sulzer, D., Shi, W., Sawasdikosol, S., Monaco, J., Batson, D., & Rajendran, G. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04264.1992 · Cited by 117
Self-citationColliver, T. L., Hess, E. J., Pothos, E. N., Sulzer, D., & Ewing, A. G. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741086.x · Cited by 98
Self-citationLi, H., Waites, C. L., Staal, R. G. W., Dobry, Y., Park, J., Sulzer, D., & Edwards, R. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.033 · Cited by 90
Self-citationPhosphorylation of a Vesicular Monoamine Transporter by Casein Kinase II
Krantz, D. E., Peter, D., Liu, Y., & Edwards, R. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6752 · Cited by 77
Self-citationNeural degeneration and the transport of neurotransmitters
Edwards, R. H. (1993) · Annals of Neurology · doi:10.1002/ana.410340504 · Cited by 69
Self-citationMONITORING MOLECULES IN NEUROSCIENCE
Jongsma, M., Bosker, F. J., Cremers, T. I. H. F., van der Hart, M., Flik, G., Westerink, B. H. C., & Boer, D. J. (1994) · Cited by 69
Rajadhyaksha, A. M., Husson, I., Satpute, S. S., Kueppenbender, K. D., Ren, J., Guerriero, R. M., Standaert, D. G., & Kosofsky, B. E. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0612-04.2004 · Cited by 55
Psychostimulants, L-type Calcium Channels, Kinases, and Phosphatases
Rajadhyaksha, A. M., & Kosofsky, B. E. (2005) · The Neuroscientist · doi:10.1177/1073858405278236 · Cited by 35
Tohgi, H., Abe, T., Saheki, M., Yamazaki, K., & Murata, T. (1997) · Journal of Neural Transmission · doi:10.1007/bf01277662 · Cited by 34
Tohgi, H., Abe, T., Yamazaki, K., et al. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11636-b · Cited by 26
Parallel modulation of striatal dopamine synthetic enzymes by second messenger pathways
Young, E. A., Duchemin, A., Neff, N. H., & Hadjiconstantinou, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00497-x · Cited by 16
Cabergoline scavenges peroxynitrite enhanced by l ‐DOPA therapy in patients with Parkinson's disease
Isobe, C., Abe, T., Kikuchi, T., Murata, T., Sato, C., & Terayama, Y. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01207.x · Cited by 9
Cited by
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
Zamponi, G. W., Striessnig, J., Koschak, A., & Dolphin, A. C. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009654 · Cited by 1,103
Metadata
- Authors
- Mosharov, E. V., Larsen, K. E., Kanter, E., Phillips, K. A., Wilson, K., Schmitz, Y., Krantz, D. E., Kobayashi, K., Edwards, R. H., & Sulzer, D.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 62
- Issue
- 2
- Pages
- 218-229
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2013503732
- Cited by
- 534
- References
- 74
- FWCI
- 23.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.